Dr. Feng ISC25 LB16 therapy options
Study principal investigator, Wayne Feng, M.D., M.S., professor of neurology and biomedical engineering at Duke University School of Medicine in Durham, North Carolina discusses the TRANSPORT 2 Trial (LB16) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Transcript (txt)
copyright American Heart Association 2025
Please see AHA/ASA Multimedia Materials Usage Policy.
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE
PROCEED